Mount Sinai Reveals Psychedelic Drugs' Therapeutic Potential
Audrey Warren, PhD, discusses her study regarding the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety. Learn more
Cancer-Associated Mutations in Brain Immune Cells May Contribute to Alzheimer's Disease
Jun 11, 2026 View All Press Releases
Mount Sinai Researchers Identify Brain “Entrapment” Patterns Associated With Depression
Jun 11, 2026 View All Press Releases
Mount Sinai Launches the Marilyn Monroe Mental Health for the Arts Program
Apr 30, 2026 View All Press Releases
A Promising Study Suggests a Blood Test Could Spot Alzheimer’s Early in Progression
Apr 21, 2026 View All Press Releases